NCT07694791Recruiting
Probiotic and Prebiotic Supplementation in Peritoneal Dialysis Patients
Impact of Synbiotic Supplementation in Peritoneal Dialysis Patients
Source: ClinicalTrials.gov · Last updated 10 Jul 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn if synbiotics work to lower inflammation in adults with chronic kidney disease who are on peritoneal dialysis. Synbiotics are daily capsules that contain a mix of probiotics (good bacteria) and prebiotics (fiber that feeds good bacteria). The main questions it aims to answer are: Do synbiotics lower the level of inflammation markers in the blood? Do synbiotics improve the nutritional status of the participants? Do synbiotics lower the number of peritonitis (peritoneal infections) episodes? Researchers will compare synbiotics to a placebo to see if the treatment works. A placebo is a look-alike capsule that contains no active ingredients. Participants will: Take 1 capsule every day for 6 months Visit the clinic at the start, at 3 months, and at 6 months for blood tests and nutrition checkups
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 4 Jul 2026
- Start date
- Oct 2025
- Primary completion date
- Jun 2027
- Lead sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Diseases
- Chronic kidney disease
- NCT number
- NCT07694791
What you commit to
- Study type: Interventional
- Planned participants: 60
- From Oct 2025 to the primary completion date, Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have taken prebiotics or probiotics (supplements that support gut health) in the month before the study starts.
- Patients who used antibiotics in the month before the study starts.
Other
- Patients who are unable to eat or receive food through a feeding tube.
- Patients who cannot attend the scheduled follow-up visits (missing the second follow-up appointment will result in being removed from the study).
- Note on non-adherence and withdrawal: Patients who are unable to take their assigned capsules regularly (taking less than 80% of the total capsules will result in being removed from the study).
Who the study is looking for
- Patients aged 18 years or older.
- Patients diagnosed with kidney disease who have been receiving peritoneal dialysis at home for at least 1 month.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario Dr. José E. González, Centro Regional de Enfermedades Renales (CRER) Coordinator of this site? Confirm its status | Monterrey | Mexico | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.